{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T21:34:09Z","timestamp":1784151249535,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.nucmedbio.2013.11.009","type":"journal-article","created":{"date-parts":[[2013,12,7]],"date-time":"2013-12-07T11:02:09Z","timestamp":1386414129000},"page":"163-170","source":"Crossref","is-referenced-by-count":20,"title":["Reactor production and electrochemical purification of 169Er: A potential step forward for its utilization in in vivo therapeutic applications"],"prefix":"10.1016","volume":"41","author":[{"given":"Rubel","family":"Chakravarty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudipta","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viju","family":"Chirayil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0005","first-page":"48S","article-title":"Radiosynovectomy in rheumatology, orthopedics, and hemophilia","volume":"46","author":"Schneider","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0010","first-page":"1536","article-title":"Chemistry and biological behaviour of Samarium-153 and Rhenium-186-labeled hydroxyapatite particles: potential radiopharmaceuticals for radiation synovectomy","volume":"34","author":"Chinol","year":"1993","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0015","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/BF00173494","article-title":"Radiation synovectomy revisited","volume":"20","author":"Deutsch","year":"1993","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0020","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0001-2998(97)80009-8","article-title":"Radiosynovectomy\u2019s clinical applications and cost effectiveness: a review","volume":"4","author":"Siegel","year":"1997","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0025","first-page":"51","article-title":"Samarium-153-particulate hydroxyapatite for radiation synovectomy: biodistribution data for chronic knee synovitis","volume":"36","author":"Clunie","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0030","first-page":"1489","article-title":"Radiation synovectomy with 166Ho-ferric hydroxide: a first experience","volume":"43","author":"Ofluoglu","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0035","first-page":"151","article-title":"Radiopharmaceuticals for diagnosis and treatment of arthritis","volume":"17","author":"Hosain","year":"1990","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0040","doi-asserted-by":"crossref","first-page":"BP12","DOI":"10.1007\/s00259-002-1058-0","article-title":"EANM procedure guidelines for radiosynovectomy","volume":"30","year":"2003","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0045","first-page":"130","article-title":"Radiation synovectomy with 90Yttrium, 186Rhenium and 169Erbium: a systamatic literature review and meta-analyses","volume":"27","author":"Van Der Zant","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0050","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0212-6982(09)00006-8","article-title":"Absorbed doseprofilesfor 32P, 90Y, 188Re, 177Lu, 153Sm and 169Er: radionuclides used in radiosynoviortheses treatment","volume":"28","author":"Torres","year":"2009","journal-title":"Rev Esp Med Nucl"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0055","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00006231-200608000-00008","article-title":"Preparation and preliminary biological evaluation of 177Lu labeled hydroxyapatite as a promising agent for radiation synovectomy of small joints","volume":"27","author":"Chakraborty","year":"2006","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0060","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.nucmedbio.2006.02.004","article-title":"175Yb-labeled Hydroxyapatite: a potential agent for use in radiation synovectomy of small joints","volume":"33","author":"Chakraborty","year":"2006","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0065","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00259-004-1712-9","article-title":"Clinical efficacy of radiation synovectomy in digital joint osteoarthritis","volume":"32","author":"Kampen","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/1568014024606502","article-title":"Intraarticular application of unsealed beta-emitting radionuclides in the treatment course of inflammatory joint diseases","volume":"1","author":"Kampen","year":"2002","journal-title":"Curr Med Chem Anti-Inflamm Anti-Allergy Agents"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0075","first-page":"22","article-title":"Radiation synovectomy: an effective alternative treatment for inflamed small joints","volume":"14","author":"Karavida","year":"2010","journal-title":"Hippokratia"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0080","first-page":"682","article-title":"Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions","volume":"41","author":"Bouchet","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0085","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1039\/jr9420000398","article-title":"Rare earth metal amalgams, part 1","volume":"1","author":"Marsh","year":"1942","journal-title":"J Chem Soc"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0090","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1039\/jr9420000523","article-title":"Rare earth metal amalgams, part 2","volume":"1","author":"Marsh","year":"1942","journal-title":"J Chem Soc"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1039\/jr9430000008","article-title":"Rare earth metal amalgams, part 3","volume":"2","author":"Marsh","year":"1943","journal-title":"J Chem Soc"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0100","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1039\/jr9430000531","article-title":"Rare earth metal amalgams, part 4","volume":"2","author":"Marsh","year":"1943","journal-title":"J Chem Soc"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0969-8051(01)00303-1","article-title":"Prepration and bioevaluation of 166Ho labeled hydroxyapatite (HA) particles for radiosynovectomy","volume":"29","author":"Unni","year":"2002","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1524\/ract.2008.1464","article-title":"177Lu-DOTMP: a viable agent for palliative radiotherapy of painful bone metastasis","volume":"96","author":"Das","year":"2008","journal-title":"Radiochim Acta"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2967\/jnmt.108.054700","article-title":"Comparison of systemic toxicities of 177Lu-DOTMP and 153Sm-EDTMP administered intravenously at equivalent skeletal doses to normal dogs","volume":"37","author":"Bryan","year":"2009","journal-title":"J Nucl Med Technol"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1524\/ract.2012.1915","article-title":"An electro-amalgamation approach to produce 175Yb suitable for radiopharmaceutical applications","volume":"100","author":"Chakravarty","year":"2012","journal-title":"Radiochim Acta"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0125","series-title":"Order issued by Govt. of India, Deptt. of Ayush, F.No. K-11020\/5\/97-DCC (AYUSH)","article-title":"Legal status of Ayurvedic, Siddha and Unani medicines","year":"2005"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0001-2998(05)80152-7","article-title":"Radiopharmaceuticals for palliation of metastatic osseous lesions: biologic and physical background","volume":"22","author":"Hosain","year":"1992","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0135","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1053\/snuc.2001.27043","article-title":"Recent advances in radionuclide therapy","volume":"31","author":"Srivastava","year":"2001","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0140","first-page":"1358","article-title":"Radiopharmaceutical therapy for palliation of bone pain from osseous metastases","volume":"45","author":"Pandit-Taskar","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0145","first-page":"2043","article-title":"Marrow-sparing effects of 117mSn(4+)diethylenetriamine-pentaacetic acid for radionuclide therapy of bone cancer","volume":"41","author":"Bishayee","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0150","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/RLU.0b013e318279bf4d","article-title":"Efficacy and safety of 177Lu-EDTMP in bone metastatic pain palliation in breast cancer and hormone refractory prostate cancer: a phase II study","volume":"38","author":"Yuan","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0155","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/1874471011205030271","article-title":"Electrochemical separation is an attractive strategy for development of radionuclide generators for medical applications","volume":"5","author":"Chakravarty","year":"2012","journal-title":"Curr Radiopharm"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0160","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.nucmedbio.2010.04.082","article-title":"An electro-amalgamation approach to isolate no-carrier-added 177Lu from neutron irradiated Yb for biomedical applications","volume":"37","author":"Chakravarty","year":"2010","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0165","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.nucmedbio.2007.10.009","article-title":"Development of an electrochemical 90Sr-90Y generator for the separation of 90Y suitable for targeted therapy","volume":"35","author":"Chakravarty","year":"2008","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0170","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1524\/ract.2009.1612","article-title":"A novel 188W\/188Re electrochemical generator with potential for medical applications","volume":"97","author":"Chakravarty","year":"2009","journal-title":"Radiochim Acta"},{"key":"10.1016\/j.nucmedbio.2013.11.009_bb0175","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nucmedbio.2009.08.010","article-title":"A novel electrochemical technique for the production of clinical grade 99mTc using (n, \u03b3)99Mo","volume":"37","author":"Chakravarty","year":"2010","journal-title":"Nucl Med Biol"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805113002473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805113002473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T06:24:20Z","timestamp":1538979860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805113002473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0969805113002473"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2013.11.009","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}